Using FTIRS to detect and limit spread of ESBL-producing bacteria in ICUs
Official title: Impact of Fourier Transform Infrared Spectroscopy (FTIRS) on the Diffusion of ESBL Producing Enterobacterales in Intensive Care Units (ICU)
Run by University Hospital, Caen · NCT05872152 · Data updated 2026-11-12
We will test whether a rapid FTIRS bacterial typing test for adult ICU patients who carry ESBL-producing Enterobacterales can reduce spread between patients.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 900 (estimated) |
| Sponsor | University Hospital, Caen Academic / other |
| Locations | 1 site (Caen) |
| Status | Recruiting |
| Started | January 8, 2024 |
| Main results expected | September 1, 2026 |
| Study ends | September 1, 2026 |
| Registry record updated | July 24, 2025 |
| Trial ID | NCT05872152 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults admitted to the participating ICU who are carriers of ESBL-producing Enterobacterales (identified by rectal swab) are the intended participants.
✕Probably not a fit
Patients who are not colonized with ESBL-producing bacteria or who are treated outside the participating ICU are unlikely to receive direct benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Multidrug-resistant Enterobacterales, particularly ESBL-producing strains, pose a high risk of cross-transmission in intensive care units. This interventional study implements routine FTIRS typing of ESBL-E from rectal swabs to deliver rapid (about one hour) strain identification that can inform infection-control measures. FTIRS results will be used alongside standard culture workflows, recognizing whole genome sequencing (WGS/MLST/SNP) as the gold standard but less feasible for continuous surveillance. The study will compare cross-transmission rates before and after systematic FTIRS implementation to determine its impact on ESBL-E spread in the ICU.
Why it matters
Potential benefit: If successful, routine FTIRS typing could reduce ICU spread of ESBL-producing bacteria and lower related infections and transmission events.
How similar studies have gone: FTIRS has shown promising rapid-typing accuracy in validation studies, but there is limited evidence from large clinical trials demonstrating reduced transmission compared with current practice or sequencing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients hospitalized in ICU * ESBL-E carrier Exclusion Criteria: * none
Where it's running
-
Chu Chen
Caen, France Recruiting
Study contacts
- Principal investigator: Camille Jeanne-Leroyer, PharmD — Caen Normandie Hospital
- Study coordinator: Camille Jeanne-Leroyer
- Email: jeanneleroyer-c@chu-caen.fr
- Phone: +33(0)231065947
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sivelestat treatment to protect organs after surgery for type A aortic dissection
In this multicenter trial, patients after surgery for type A aortic dissection receive sivelestat or a placebo to see if it helps protect organ function.
-
Beacons for ICU: extra clinician alerts in ICU sub-units
This study tests whether adding the ICU Beacon clinician awareness system to standard ICU care improves outcomes for adults with respiratory or circulatory failure compared with standard care alone.
-
Electronic archive for treating severe organ failure and liver transplantation
This study looks at medical records of patients with severe liver failure to see how well different treatments work and improve liver transplant care over the next 10 years.
-
Effect of Traditional Chinese Medicine on Organ Failure in Critically Ill Patients
This study is testing whether traditional Chinese medicine can help critically ill patients with organ failure in the ICU feel better and recover faster.
-
Heterogeneity of Critical Illness in ICU Patients
This study tests how patient characteristics relate to the severity of organ failure in adults admitted to the ICU with critical illness.
-
Using Indomethacin to Treat Acute Pancreatitis
This study is testing if giving indomethacin through the rectum can help people with acute pancreatitis have fewer complications and live longer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.